Press Releases

Press Releases

Press Releases

Jul 31, 2025
BALA CYNWYD, Pa. , July 31, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of its previously announced underwritten public offering of
Displaying 11 - 20 of 95